Session date: 
12/09/2021 - 7:30am to 8:30am

Learning Objectives
Upon conclusion of the activity, participants should be able to:

  1. Recognize the common antimicrobial susceptibility profiles and mechanisms of resistance of Enterococcus spp.
  2. Identify challenges in daptomycin dosing and MCI interpretation for VRE
  3. Identify alternative therapeutic approaches for the management of complicated VRE infections including infective endocarditis



ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.

    Presenter: 
    Said El Zein, M.D.
    Co-presenter: 
    Michaela Wermers, Pharm.D., R.Ph.
    Support location: 
    Minnesota

    Please login or register to take this course.
    Support location: 
    Minnesota